{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-005699","form_type":"8-K","ticker":"SFES","cik":"0000086115","company_name":"SAFEGUARD SCIENTIFICS INC","filed_at":"2022-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.072111+00:00","generated_at":"2026-06-27T00:34:20.161903+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Safeguard Scientifics reports $60.8M cash proceeds from 2021 exits; initiates strategic review","bullets":["Repurchased 4.5M shares in 2021, including 4.3M via Dutch auction at $9.06 per share.","Received $44.8M from Flashtalking exit, $32.5M gain; $3.5M cash + $15.3M preferred equity from Zipnosis.","BHG IPO converted preferred to 1.3M common shares; fair value fell to $4.5M by year-end.","Deployments totaled $2.7M in 2021; funded $2M convertible loan to Prognos Health post-year-end.","Board initiated evaluation of strategic alternatives to enhance shareholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-005699","json":"https://secwatch.observer/filing/0001437749-22-005699.json","markdown":"https://secwatch.observer/filing/0001437749-22-005699.md","text":"https://secwatch.observer/filing/0001437749-22-005699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/86115/000143774922005699/0001437749-22-005699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/86115/000143774922005699/sfe20220309_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T00:34:20.161903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}